Science Current Events | Science News | Brightsurf.com
 

Cell skeleton may hold key to overcoming drug resistance in cancer

October 04, 2007

Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cell's cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

"Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.

"This is the first scientific evidence for the broader implications of abnormal expression of this protein.

"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.

Research Australia


Related Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles


Non-integrating viral vector delivers chemotherapy-sensitizing gene to pancreatic cancer cells
New Rochelle, NY, February 26, 2016--A novel HIV-based lentiviral vector can introduce a gene to pancreatic tumor cells that makes them more sensitive to the chemotherapeutic drug gemcitabine, without integrating into cellular DNA.

Scientists pioneer 3-D-printed drug delivering micro-needles
Researchers have developed a new technique to produce a 3D 'micro-printed' array of needles capable of drug delivery.

Innovative light therapy reaches deep tumors
Light long has been used to treat cancer. But phototherapy is only effective where light easily can reach, limiting its use to cancers of the skin and in areas accessible with an endoscope, such as the gastrointestinal tract.

CNIO associates rare gene variants with side effects from chemotherapy with paclitaxel
Paclitaxel is a chemotherapeutic drug that has been shown to be highly effective when treating solid tumours, such as breast, ovarian and lung tumours.

Major discovery on the mechanism of drug resistance in leukemia and other cancers
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) and her collaborators.

Genetic aberration paves the way for new treatment of cancer disease
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients.

Nanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.

More Effective Immunotherapy for Melanoma Hinges on Blocking Suppressive Factors, Moffitt Cancer Center Researchers Say
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them.

CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.
More Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles

Cough Cures: The Complete Guide to the Best Natural Remedies and Over-the-Counter Drugs for Acute and Chronic Coughs

Cough Cures: The Complete Guide to the Best Natural Remedies and Over-the-Counter Drugs for Acute and Chronic Coughs
by Gustavo Ferrer MD (Author), Burke Lennihan RN (Author), Howard Vanes (Illustrator), Jayson Escalona (Illustrator)


In this groundbreaking book you will find the best of both worlds, bridging the gap between conventional and holistic medicine. Cough Cures is not just about coughs - it's about natural alternatives for antibiotics, cough syrups, pain and sleeping medications, even antacids. Dr. Gus Ferrer a renowned pulmonologist and Burke Lennihan RN, a certified practitioner in holistic medicine, bring you a book packed with natural cures and guides to the best over-the-counter drugs for acute and chronic cough.

You will also learn about acupressure, breathing exercises, and other techniques. The recommendations for natural remedies are documented with more than 200 research studies, so that both parents and physicians can feel confident in using them. COUGH CURES has the answers you’ve...

Physicians' Cancer Chemotherapy Drug Manual 2016

Physicians' Cancer Chemotherapy Drug Manual 2016
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2016, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens―both on- and off-label―for the treatment of all the major cancers. SPECIAL FEATURES: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like belinostat, blinatumomab, lenvatinib, nivolumab, olaparib, palbociclib, panobinostat, pembrolizumab, and ramucirumab • A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. • Diagrams...

The Emperor of All Maladies: A Biography of Cancer

The Emperor of All Maladies: A Biography of Cancer
by Siddhartha Mukherjee (Author)


Winner of the Pulitzer Prize, and now a documentary from Ken Burns on PBS, The Emperor of All Maladies is a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence.

Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly lucid and eloquent chronicle of a disease humans have lived with—and perished from—for more than five thousand years.

The story of cancer is a story of human ingenuity, resilience, and perseverance,...

Basic and Clinical Pharmacology 13 E

Basic and Clinical Pharmacology 13 E
by Bertram Katzung (Author), Anthony Trevor (Author)


Gain a full understanding of the basic science and clinical use of drugs with the most up-to-date and comprehensive pharmacology text in the health sciences400 ILLUSTRATIONS--MANY IN FULL COLORA Doody's Core Title for 2015!Coverage that spans every aspect of medical pharmacology: Encompasses every aspect of medical pharmacology including botanicals and over-the-counter drugs New chapter on pharmacogenomics with important examples Emphasis is placed on discussion of drug groups and prototypes Clinically relevant, the book includes sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effects Full-color presentation with more than 400 illustrations Case studies introduce clinical problems in most chapters Summary tables and diagrams...

Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition (Katzung & Trevor's Pharmacology Examination & Board Review)

Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition (Katzung & Trevor's Pharmacology Examination & Board Review)
by Anthony Trevor (Author), Bertram Katzung (Author), Susan Masters (Author), Marieke Knuidering-Hall (Author)


MORE THAN 1000 Q&As PREPARE YOU FOR MEDICAL PHARMACOLOGY COURSE EXAMS AND BOARD EXAMINATIONS From the authors of pharmacology's #1 textbook, Katzung & Trevor's Basic & Clinical Pharmacology, Twelfth Edition, this review delivers a clear, concise review of fundamental concepts backed by more than 1,000 review questions and answers. The chapter-based approach facilitates use with course notes or larger texts. Outstanding learning aids include: Short discussion of the major concepts that underlie basic principles or specific drug groups Explanatory figures and tables Review questions followed by answers and explanations Drug trees in drug-oriented chapters that visually organize drug groups A list of high-yield terms and definitions you need to know Skill Keeper Questions that prompt you...

Herb-Drug Interactions in Oncology, 2nd edition

Herb-Drug Interactions in Oncology, 2nd edition
by Barrie Cassileth (Author), K. Simon Yeung (Author), Jyothirmai Gubili (Author)


The book provides science-based information for the medical community about herbal remedies, other dietary supplements, and non-mainstream products promoted as cancer treatments. Each herb or remedy description is accompanied by information as to its origin, most common uses, benefits, and risks/dangers. The book provides detailed information on over 250 remedies and describes their constituents, mechanisms of action, adverse reactions, pharmacokinetics, and contraindications. Information on each herb or other remedy was developed through careful and critical reviews of research conducted by experts in pharmacy, botanicals, and complementary therapies. Each herb or product is described in terms of the following sections: common name, scientific name, key words, clinical summary, herbal...

Basic Principles of Drug Discovery and Development

Basic Principles of Drug Discovery and Development
by Benjamin Blass (Author)


Basic Principles of Drug Discovery and Development presents the multifaceted process of identifying a new drug in the modern era, providing comprehensive explanations of enabling technologies such as high throughput screening, structure based drug design, molecular modeling, pharmaceutical profiling, and translational medicine, all areas that have become critical steps in the successful development of marketable therapeutics. The text introduces the fundamental principles of drug discovery and development, also discussing important drug targets by class, in vitro screening methods, medicinal chemistry strategies in drug design, principles in pharmacokinetics and pharmacodynamics, animal models of disease states, clinical trial basics, and selected business aspects of the drug discovery...

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)
by Benjamin Bonavida (Editor)


This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies.

Cancer Chemotherapeutic Agents (ACS Professional Reference Book)

Cancer Chemotherapeutic Agents (ACS Professional Reference Book)
by William O. Foye (Editor)


An authoritative treatment of the discovery, development, and understanding of cancer chemotherapeutic agents. Addresses the major classes of chemotherapeutic agents, including antimetabolites, agents that react with DNA, inhibitors of transcription enzymes, topoisomerase inhibitors, DNA minor-groove binding compounds, antimotic agents, bleomycin group antitumor antibiotics, antihormones, paclitaxels, and photochemically activated agents. Provides an overview of the various classes of agents now considered important. Examines a method for determining the similarity of mechanism of the compounds in a given class.

Drug Resistance in Cancer Cells

Drug Resistance in Cancer Cells
by Kapil Mehta (Editor), Zahid H. Siddik (Editor), Susan E. Bates (Editor)


It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosisand 565,650individualswould die of cancer (Jemal et al. 2008).Since the vast majority of patients dying of cancer will have had anticancer therapy, both c- ventional chemotherapy and novel targeted therapy, it can be concluded that these patients are dying with drug resistant cancer. The term multidrug resistance is also apt – in that these patients die after having undergone multiple rounds of different and structurally unrelated cancer therapies. However, for some, the concept of m- tidrug resistance is a worn out idea, stemming from disappointment with the drug resistancereversalstrategiesthatwerecarriedoutinthe1990susingpumpinhibitors to block drug resistance mediated by P-glycoprotein, product of...

© 2016 BrightSurf.com